Elovanoids are a novel class of homeostatic lipid mediators that protect neural cell integrity upon injury.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28959727)

Published in Sci Adv on September 27, 2017

Authors

Surjyadipta Bhattacharjee1, Bokkyoo Jun1, Ludmila Belayev1, Jessica Heap1, Marie-Audrey Kautzmann1, Andre Obenaus2, Hemant Menghani1,3, Shawn J Marcell1, Larissa Khoutorova1, Rong Yang4, Nicos A Petasis4, Nicolas G Bazan1

Author Affiliations

1: Neuroscience Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
2: Department of Pediatrics, University of California, Irvine, Irvine, CA 92697, USA.
3: Division of Hematology-Oncology, Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital of New Orleans, New Orleans, LA 70118, USA.
4: Department of Chemistry, Loker Hydrocarbon Research Institute, University of Southern California, Los Angeles, CA 90033, USA.

Articles cited by this

Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med (2002) 10.10

Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci (2002) 7.57

Ischemia and reperfusion--from mechanism to translation. Nat Med (2011) 6.64

The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53

Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53

The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A (2004) 4.28

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem (2003) 3.80

Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke (1996) 3.16

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol (2006) 3.03

Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A (2001) 2.16

Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr (2011) 1.88

Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann Neurol (2010) 1.67

Astrocytes in cerebral ischemic injury: morphological and general considerations. Glia (2005) 1.66

Increase in blood-brain barrier permeability, oxidative stress, and activated microglia in a rat model of blast-induced traumatic brain injury. J Neurosci Res (2010) 1.45

Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci (2007) 1.40

Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am J Hum Genet (2011) 1.31

Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev (2010) 1.26

Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp Neurol (2006) 1.24

Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta (2014) 1.14

Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. J Neurosci (2011) 0.98

Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci (2014) 0.97

Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp Neurol (2012) 0.96

Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome. Eur Neurol (2010) 0.91

Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer. Tetrahedron Lett (2012) 0.88

In vitro oxygen-glucose deprivation to study ischemic cell death. Methods Mol Biol (2015) 0.85

Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans. Adv Exp Med Biol (2016) 0.82

The blood-brain barrier after stroke: Structural studies and the role of transcytotic vesicles. J Cereb Blood Flow Metab (2016) 0.81

Beyond neuroprotection to brain repair: exploring the next frontier in clinical neuroscience to expand the therapeutic window for stroke. Transl Stroke Res (2010) 0.79

Normobaric oxygen treatment in acute ischemic stroke: a clinical perspective. Med Gas Res (2016) 0.79

Structural chromosome aberrations cause swelling of the nucleus. Genes Environ (2016) 0.77

Global stroke statistics. Int J Stroke (2016) 0.77

IL-10 Promotes Neurite Outgrowth and Synapse Formation in Cultured Cortical Neurons after the Oxygen-Glucose Deprivation via JAK1/STAT3 Pathway. Sci Rep (2016) 0.75